Skip to content

The Effect of propofol and midazolam on patients headache after spinal anesthesia

The effect of propofol and midazolam sedation dose on patients headache after spinal anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015120712312N3
Enrollment
80
Registered
2016-01-21
Start date
2015-12-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post spinal headache. Other reaction to spinal and lumbar puncture

Interventions

Intervention 1: Prescription of intravenous propofol 30 ug/kg/min for sedation post spinal. Intervention 2: Prescription of intravenous midazolam /02mg/kg for sedation post spinal.
Treatment - Drugs
Prescription of intravenous propofol 30 ug/kg/min for sedation post spinal
Prescription of intravenous midazolam /02mg/kg for sedation post spinal

Sponsors

Deputy of Research and technolgy of Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients who have been admitted as an elective surgery between 20 and 80years old? sign the written consent. Exclusion Criteria: the patients aren’t included in the first and second class (based on the American Society of Anesthesia classification); not to sign the written consent; to have an underlying disease; to report any acute or chronic headache before spinal puncture; to take pain medication in the last two days; coagulopathy disorders; hemodynamic disorders; abscesses and local infection of the soft tissue or skin in the injection site; severe restlessness; brain lesion; severe mental disorders and addictions.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Headache. Timepoint: q 6 hr for 24 houre. Method of measurement: vas and check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Taghi Khodadadi

Gonabad University of Medical Sciences

dr_khodadadi_m@yahoo.com+98 51 5723 1114

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026